Next Article in Journal
Preparation of Porous Scaffolds from Silk Fibroin Extracted from the Silk Gland of Bombyx mori (B. mori)
Next Article in Special Issue
Effect of PACAP in Central and Peripheral Nerve Injuries
Previous Article in Journal
Effects of Methylmercury Contained in a Diet Mimicking the Wayana Amerindians Contamination through Fish Consumption: Mercury Accumulation, Metallothionein Induction, Gene Expression Variations, and Role of the Chemokine CCL2
Previous Article in Special Issue
Dietary Supplementations as Neuroprotective Therapies: Focus on NT-020 Diet Benefits in a Rat Model of Stroke
Open AccessReview

Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke

1
Department of Physiology, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan
2
Department of Neurosurgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan
3
Uchikado Neuro-Spine Clinic, 1-2-3 Naka, Hakata-ku, Fukuoka 812-0893, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(6), 7739-7761; https://doi.org/10.3390/ijms13067739
Received: 15 May 2012 / Revised: 15 June 2012 / Accepted: 19 June 2012 / Published: 21 June 2012
(This article belongs to the Special Issue Neuroprotective Strategies 2012)
Stroke is an enormous public health problem with an imperative need for more effective therapies. In therapies for ischemic stroke, tissue plasminogen activators, antiplatelet agents and anticoagulants are used mainly for their antithrombotic effects. However, free radical scavengers, minocycline and growth factors have shown neuroprotective effects in the treatment of stroke, while antihypertensive drugs, lipid-lowering drugs and hypoglycemic drugs have shown beneficial effects for the prevention of stroke. In the present review, we evaluate the treatment and prevention of stroke in light of clinical studies and discuss new anti-stroke effects other than the main effects of drugs, focusing on optimal pharmacotherapy. View Full-Text
Keywords: stroke; neuroprotective effect; clinical drugs stroke; neuroprotective effect; clinical drugs
MDPI and ACS Style

Kikuchi, K.; Uchikado, H.; Morioka, M.; Murai, Y.; Tanaka, E. Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke. Int. J. Mol. Sci. 2012, 13, 7739-7761.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop